APO Research
Talk to an analyst

APO RESEARCH · REPORT

DTaP and Tdap Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global DTaP and Tdap Vaccines Industry Growth and Trends Forecast to 2032

19 December 2025108 pages

Choose your research edition.

Industry ResearchDTaP and Tdap Vaccines Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal DTaP and Tdap Vaccines Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal DTaP and Tdap Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DTaP and Tdap Vaccines Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal DTaP and Tdap Vaccines Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global DTaP and Tdap Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for DTaP and Tdap Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for DTaP and Tdap Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for DTaP and Tdap Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of DTaP and Tdap Vaccines include Johnson & Johnson, Novartis AG, Lanzhou Institute of Biological Products Co., Ltd, Pfizer Inc, GlaxoSmithKline, AstraZeneca, Seqirus, Sanofi Pasteur and Protein Sciences Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global DTaP and Tdap Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The DTaP and Tdap Vaccines market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global DTaP and Tdap Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to DTaP and Tdap Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global DTaP and Tdap Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

DTaP and Tdap Vaccines Market by Company

Johnson & Johnson

Novartis AG

Lanzhou Institute of Biological Products Co., Ltd

Pfizer Inc

GlaxoSmithKline

AstraZeneca

Seqirus

Sanofi Pasteur

Protein Sciences Corporation

Merck Sharp & Dohme Corp

Emergent BioSolutions Inc

Astellas Pharma US, Inc

DTaP and Tdap Vaccines Segment by Type

Tdap

DTaP

Td

DTaP and Tdap Vaccines Segment by Application

Adult

Pediatric

DTaP and Tdap Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DTaP and Tdap Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DTaP and Tdap Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DTaP and Tdap Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of DTaP and Tdap Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of DTaP and Tdap Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tdap Table 2. Major Company of DTaP Table 3. Major Company of Td Table 4. Global DTaP and Tdap Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global DTaP and Tdap Vaccines Sales by Type (2021-2026) & (W Units) Table 6. Global DTaP and Tdap Vaccines Sales Market Share in Volume by Type (2021-2026) Table 7. Global DTaP and Tdap Vaccines Sales by Type (2021-2026) & (US$ Million) Table 8. Global DTaP and Tdap Vaccines Sales Market Share in Value by Type (2021-2026) Table 9. Global DTaP and Tdap Vaccines Price by Type (2021-2026) & (US$/Unit) Table 10. Global DTaP and Tdap Vaccines Sales by Type (2027-2032) & (W Units) Table 11. Global DTaP and Tdap Vaccines Sales Market Share in Volume by Type (2027-2032) Table 12. Global DTaP and Tdap Vaccines Sales by Type (2027-2032) & (US$ Million) Table 13. Global DTaP and Tdap Vaccines Sales Market Share in Value by Type (2027-2032) Table 14. Global DTaP and Tdap Vaccines Price by Type (2027-2032) & (US$/Unit) Table 15. North America DTaP and Tdap Vaccines Sales by Type (2021-2026) & (W Units) Table 16. North America DTaP and Tdap Vaccines Sales by Type (2021-2026) & (US$ Million) Table 17. Europe DTaP and Tdap Vaccines Sales by Type (2021-2026) & (W Units) Table 18. Europe DTaP and Tdap Vaccines Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific DTaP and Tdap Vaccines Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific DTaP and Tdap Vaccines Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America DTaP and Tdap Vaccines Sales by Type (2021-2026) & (W Units) Table 22. Latin America DTaP and Tdap Vaccines Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa DTaP and Tdap Vaccines Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa DTaP and Tdap Vaccines Sales by Type (2021-2026) & (US$ Million) Table 25. DTaP and Tdap Vaccines Industry Trends Table 26. DTaP and Tdap Vaccines Industry Drivers Table 27. DTaP and Tdap Vaccines Industry Opportunities and Challenges Table 28. DTaP and Tdap Vaccines Industry Restraints Table 29. Global DTaP and Tdap Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global DTaP and Tdap Vaccines Revenue Market Share by Company (2021-2026) Table 31. Global DTaP and Tdap Vaccines Sales by Company (2021-2026) & (W Units) Table 32. Global DTaP and Tdap Vaccines Sales Share by Company (2021-2026) Table 33. Global DTaP and Tdap Vaccines Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global DTaP and Tdap Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global DTaP and Tdap Vaccines Major Company Production Sites and Headquarters Table 36. Global DTaP and Tdap Vaccines Company, Product Type & Application Table 37. Global DTaP and Tdap Vaccines Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global DTaP and Tdap Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global DTaP and Tdap Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global DTaP and Tdap Vaccines Sales by Region (2021-2026) & (W Units) Table 42. Global DTaP and Tdap Vaccines Sales Market Share in Volume by Region (2021-2026) Table 43. Global DTaP and Tdap Vaccines Sales by Region (2021-2026) & (US$ Million) Table 44. Global DTaP and Tdap Vaccines Sales Market Share in Value by Region (2021-2026) Table 45. Global DTaP and Tdap Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global DTaP and Tdap Vaccines Sales by Region (2027-2032) & (W Units) Table 47. Global DTaP and Tdap Vaccines Sales Market Share in Volume by Region (2027-2032) Table 48. Global DTaP and Tdap Vaccines Sales by Region (2027-2032) & (US$ Million) Table 49. Global DTaP and Tdap Vaccines Sales Market Share in Value by Region (2027-2032) Table 50. Global DTaP and Tdap Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global DTaP and Tdap Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global DTaP and Tdap Vaccines Sales by Application (2021-2026) & (W Units) Table 53. Global DTaP and Tdap Vaccines Sales Market Share in Volume by Application (2021-2026) Table 54. Global DTaP and Tdap Vaccines Sales by Application (2021-2026) & (US$ Million) Table 55. Global DTaP and Tdap Vaccines Sales Market Share in Value by Application (2021-2026) Table 56. Global DTaP and Tdap Vaccines Price by Application (2021-2026) & (US$/Unit) Table 57. Global DTaP and Tdap Vaccines Sales by Application (2027-2032) & (W Units) Table 58. Global DTaP and Tdap Vaccines Sales Market Share in Volume by Application (2027-2032) Table 59. Global DTaP and Tdap Vaccines Sales by Application (2027-2032) & (US$ Million) Table 60. Global DTaP and Tdap Vaccines Sales Market Share in Value by Application (2027-2032) Table 61. Global DTaP and Tdap Vaccines Price by Application (2027-2032) & (US$/Unit) Table 62. North America DTaP and Tdap Vaccines Sales by Application (2021-2026) & (W Units) Table 63. North America DTaP and Tdap Vaccines Sales by Application (2021-2026) & (US$ Million) Table 64. Europe DTaP and Tdap Vaccines Sales by Application (2021-2026) & (W Units) Table 65. Europe DTaP and Tdap Vaccines Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific DTaP and Tdap Vaccines Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific DTaP and Tdap Vaccines Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America DTaP and Tdap Vaccines Sales by Application (2021-2026) & (W Units) Table 69. Latin America DTaP and Tdap Vaccines Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa DTaP and Tdap Vaccines Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa DTaP and Tdap Vaccines Sales by Application (2021-2026) & (US$ Million) Table 72. Johnson & Johnson Company Information Table 73. Johnson & Johnson Business Overview Table 74. Johnson & Johnson DTaP and Tdap Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Johnson & Johnson DTaP and Tdap Vaccines Product Portfolio Table 76. Johnson & Johnson Recent Development Table 77. Novartis AG Company Information Table 78. Novartis AG Business Overview Table 79. Novartis AG DTaP and Tdap Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Novartis AG DTaP and Tdap Vaccines Product Portfolio Table 81. Novartis AG Recent Development Table 82. Lanzhou Institute of Biological Products Co., Ltd Company Information Table 83. Lanzhou Institute of Biological Products Co., Ltd Business Overview Table 84. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Product Portfolio Table 86. Lanzhou Institute of Biological Products Co., Ltd Recent Development Table 87. Pfizer Inc Company Information Table 88. Pfizer Inc Business Overview Table 89. Pfizer Inc DTaP and Tdap Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Pfizer Inc DTaP and Tdap Vaccines Product Portfolio Table 91. Pfizer Inc Recent Development Table 92. GlaxoSmithKline Company Information Table 93. GlaxoSmithKline Business Overview Table 94. GlaxoSmithKline DTaP and Tdap Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. GlaxoSmithKline DTaP and Tdap Vaccines Product Portfolio Table 96. GlaxoSmithKline Recent Development Table 97. AstraZeneca Company Information Table 98. AstraZeneca Business Overview Table 99. AstraZeneca DTaP and Tdap Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. AstraZeneca DTaP and Tdap Vaccines Product Portfolio Table 101. AstraZeneca Recent Development Table 102. Seqirus Company Information Table 103. Seqirus Business Overview Table 104. Seqirus DTaP and Tdap Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Seqirus DTaP and Tdap Vaccines Product Portfolio Table 106. Seqirus Recent Development Table 107. Sanofi Pasteur Company Information Table 108. Sanofi Pasteur Business Overview Table 109. Sanofi Pasteur DTaP and Tdap Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Sanofi Pasteur DTaP and Tdap Vaccines Product Portfolio Table 111. Sanofi Pasteur Recent Development Table 112. Protein Sciences Corporation Company Information Table 113. Protein Sciences Corporation Business Overview Table 114. Protein Sciences Corporation DTaP and Tdap Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Protein Sciences Corporation DTaP and Tdap Vaccines Product Portfolio Table 116. Protein Sciences Corporation Recent Development Table 117. Merck Sharp & Dohme Corp Company Information Table 118. Merck Sharp & Dohme Corp Business Overview Table 119. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product Portfolio Table 121. Merck Sharp & Dohme Corp Recent Development Table 122. Emergent BioSolutions Inc Company Information Table 123. Emergent BioSolutions Inc Business Overview Table 124. Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Emergent BioSolutions Inc DTaP and Tdap Vaccines Product Portfolio Table 126. Emergent BioSolutions Inc Recent Development Table 127. Astellas Pharma US, Inc Company Information Table 128. Astellas Pharma US, Inc Business Overview Table 129. Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Astellas Pharma US, Inc DTaP and Tdap Vaccines Product Portfolio Table 131. Astellas Pharma US, Inc Recent Development Table 132. North America DTaP and Tdap Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 133. North America DTaP and Tdap Vaccines Sales by Country (2021-2026) & (W Units) Table 134. North America DTaP and Tdap Vaccines Sales Market Share by Country (2021-2026) Table 135. North America DTaP and Tdap Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 136. North America DTaP and Tdap Vaccines Sales Market Share Forecast by Country (2027-2032) Table 137. North America DTaP and Tdap Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. North America DTaP and Tdap Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 139. North America DTaP and Tdap Vaccines Market Share by Country (2021-2026) Table 140. North America DTaP and Tdap Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. North America DTaP and Tdap Vaccines Market Share Forecast by Country (2027-2032) Table 142. Europe DTaP and Tdap Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 143. Europe DTaP and Tdap Vaccines Sales by Country (2021-2026) & (W Units) Table 144. Europe DTaP and Tdap Vaccines Sales Market Share by Country (2021-2026) Table 145. Europe DTaP and Tdap Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 146. Europe DTaP and Tdap Vaccines Sales Market Share Forecast by Country (2027-2032) Table 147. Europe DTaP and Tdap Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Europe DTaP and Tdap Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 149. Europe DTaP and Tdap Vaccines Market Share by Country (2021-2026) Table 150. Europe DTaP and Tdap Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Europe DTaP and Tdap Vaccines Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific DTaP and Tdap Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific DTaP and Tdap Vaccines Sales by Country (2021-2026) & (W Units) Table 154. Asia-Pacific DTaP and Tdap Vaccines Sales Market Share by Country (2021-2026) Table 155. Asia-Pacific DTaP and Tdap Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 156. Asia-Pacific DTaP and Tdap Vaccines Sales Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific DTaP and Tdap Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific DTaP and Tdap Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 159. Asia-Pacific DTaP and Tdap Vaccines Market Share by Country (2021-2026) Table 160. Asia-Pacific DTaP and Tdap Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Asia-Pacific DTaP and Tdap Vaccines Market Share Forecast by Country (2027-2032) Table 162. Latin America DTaP and Tdap Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 163. Latin America DTaP and Tdap Vaccines Sales by Country (2021-2026) & (W Units) Table 164. Latin America DTaP and Tdap Vaccines Sales Market Share by Country (2021-2026) Table 165. Latin America DTaP and Tdap Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 166. Latin America DTaP and Tdap Vaccines Sales Market Share Forecast by Country (2027-2032) Table 167. Latin America DTaP and Tdap Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Latin America DTaP and Tdap Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 169. Latin America DTaP and Tdap Vaccines Market Share by Country (2021-2026) Table 170. Latin America DTaP and Tdap Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Latin America DTaP and Tdap Vaccines Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa DTaP and Tdap Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa DTaP and Tdap Vaccines Sales by Country (2021-2026) & (W Units) Table 174. Middle East and Africa DTaP and Tdap Vaccines Sales Market Share by Country (2021-2026) Table 175. Middle East and Africa DTaP and Tdap Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 176. Middle East and Africa DTaP and Tdap Vaccines Sales Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa DTaP and Tdap Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa DTaP and Tdap Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 179. Middle East and Africa DTaP and Tdap Vaccines Market Share by Country (2021-2026) Table 180. Middle East and Africa DTaP and Tdap Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Middle East and Africa DTaP and Tdap Vaccines Market Share Forecast by Country (2027-2032) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. DTaP and Tdap Vaccines Distributors List Table 185. DTaP and Tdap Vaccines Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. DTaP and Tdap Vaccines Image Figure 2. Global DTaP and Tdap Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DTaP and Tdap Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global DTaP and Tdap Vaccines Sales (2021-2032) & (W Units) Figure 5. Tdap Image Figure 6. Global Tdap Sales YoY Growth (2021-2032) & (W Units) Figure 7. DTaP Image Figure 8. Global DTaP Sales YoY Growth (2021-2032) & (W Units) Figure 9. Td Image Figure 10. Global Td Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global DTaP and Tdap Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global DTaP and Tdap Vaccines Market Share by Type 2025 VS 2032 Figure 13. North America DTaP and Tdap Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. North America DTaP and Tdap Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Europe DTaP and Tdap Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Europe DTaP and Tdap Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific DTaP and Tdap Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific DTaP and Tdap Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Latin America DTaP and Tdap Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Latin America DTaP and Tdap Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa DTaP and Tdap Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa DTaP and Tdap Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 DTaP and Tdap Vaccines Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Adult Image Figure 26. Global Adult Sales YoY Growth (2021-2032) & (W Units) Figure 27. Pediatric Image Figure 28. Global Pediatric Sales YoY Growth (2021-2032) & (W Units) Figure 29. Global DTaP and Tdap Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global DTaP and Tdap Vaccines Market Share by Application 2025 VS 2032 Figure 31. North America DTaP and Tdap Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. North America DTaP and Tdap Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Europe DTaP and Tdap Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Europe DTaP and Tdap Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific DTaP and Tdap Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific DTaP and Tdap Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Latin America DTaP and Tdap Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Latin America DTaP and Tdap Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa DTaP and Tdap Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa DTaP and Tdap Vaccines Sales Market Share in Value by Application in 2025 Figure 41. North America DTaP and Tdap Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 42. North America DTaP and Tdap Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America DTaP and Tdap Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America DTaP and Tdap Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe DTaP and Tdap Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. Europe DTaP and Tdap Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe DTaP and Tdap Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe DTaP and Tdap Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific DTaP and Tdap Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Asia-Pacific DTaP and Tdap Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific DTaP and Tdap Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific DTaP and Tdap Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America DTaP and Tdap Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Latin America DTaP and Tdap Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America DTaP and Tdap Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America DTaP and Tdap Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa DTaP and Tdap Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Middle East and Africa DTaP and Tdap Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa DTaP and Tdap Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa DTaP and Tdap Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. DTaP and Tdap Vaccines Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. DTaP and Tdap Vaccines Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tdap
  • DTaP
  • Td
Applications
  • Adult
  • Pediatric
Companies covered
  • Johnson & Johnson
  • Novartis AG
  • Lanzhou Institute of Biological Products Co., Ltd
  • Pfizer Inc
  • GlaxoSmithKline
  • AstraZeneca
  • Seqirus
  • Sanofi Pasteur
  • Protein Sciences Corporation
  • Merck Sharp & Dohme Corp
  • Emergent BioSolutions Inc
  • Astellas Pharma US, Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global DTaP and Tdap Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global DTaP and Tdap Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 DTaP and Tdap Vaccines Market by Type
  6. 1.3.1 Tdap
  7. 1.3.2 DTaP
  8. 1.3.3 Td
  9. 1.4 Global DTaP and Tdap Vaccines Market Size by Type
  10. 1.4.1 Global DTaP and Tdap Vaccines Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global DTaP and Tdap Vaccines Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global DTaP and Tdap Vaccines Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America DTaP and Tdap Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe DTaP and Tdap Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific DTaP and Tdap Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America DTaP and Tdap Vaccines Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa DTaP and Tdap Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 DTaP and Tdap Vaccines Industry Trends
  2. 2.2 DTaP and Tdap Vaccines Industry Drivers
  3. 2.3 DTaP and Tdap Vaccines Industry Opportunities and Challenges
  4. 2.4 DTaP and Tdap Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by DTaP and Tdap Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by DTaP and Tdap Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by DTaP and Tdap Vaccines Price (2021-2026)
  4. 3.4 Global DTaP and Tdap Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global DTaP and Tdap Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global DTaP and Tdap Vaccines Company, Product Type & Application
  7. 3.7 Global DTaP and Tdap Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global DTaP and Tdap Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 DTaP and Tdap Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 DTaP and Tdap Vaccines Tier 1, Tier 2, and Tier 3
4 DTaP and Tdap Vaccines Regional Status and Outlook
  1. 4.1 Global DTaP and Tdap Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global DTaP and Tdap Vaccines Historic Market Size by Region
  3. 4.2.1 Global DTaP and Tdap Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global DTaP and Tdap Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global DTaP and Tdap Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global DTaP and Tdap Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global DTaP and Tdap Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global DTaP and Tdap Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global DTaP and Tdap Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 DTaP and Tdap Vaccines by Application
  1. 5.1 DTaP and Tdap Vaccines Market by Application
  2. 5.1.1 Adult
  3. 5.1.2 Pediatric
  4. 5.2 Global DTaP and Tdap Vaccines Market Size by Application
  5. 5.2.1 Global DTaP and Tdap Vaccines Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global DTaP and Tdap Vaccines Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global DTaP and Tdap Vaccines Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America DTaP and Tdap Vaccines Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe DTaP and Tdap Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific DTaP and Tdap Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America DTaP and Tdap Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa DTaP and Tdap Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson DTaP and Tdap Vaccines Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Novartis AG
  8. 6.2.1 Novartis AG Company Information
  9. 6.2.2 Novartis AG Business Overview
  10. 6.2.3 Novartis AG DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis AG DTaP and Tdap Vaccines Product Portfolio
  12. 6.2.5 Novartis AG Recent Developments
  13. 6.3 Lanzhou Institute of Biological Products Co., Ltd
  14. 6.3.1 Lanzhou Institute of Biological Products Co., Ltd Company Information
  15. 6.3.2 Lanzhou Institute of Biological Products Co., Ltd Business Overview
  16. 6.3.3 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Product Portfolio
  18. 6.3.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments
  19. 6.4 Pfizer Inc
  20. 6.4.1 Pfizer Inc Company Information
  21. 6.4.2 Pfizer Inc Business Overview
  22. 6.4.3 Pfizer Inc DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Inc DTaP and Tdap Vaccines Product Portfolio
  24. 6.4.5 Pfizer Inc Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline DTaP and Tdap Vaccines Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AstraZeneca DTaP and Tdap Vaccines Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
  37. 6.7 Seqirus
  38. 6.7.1 Seqirus Company Information
  39. 6.7.2 Seqirus Business Overview
  40. 6.7.3 Seqirus DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Seqirus DTaP and Tdap Vaccines Product Portfolio
  42. 6.7.5 Seqirus Recent Developments
  43. 6.8 Sanofi Pasteur
  44. 6.8.1 Sanofi Pasteur Company Information
  45. 6.8.2 Sanofi Pasteur Business Overview
  46. 6.8.3 Sanofi Pasteur DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sanofi Pasteur DTaP and Tdap Vaccines Product Portfolio
  48. 6.8.5 Sanofi Pasteur Recent Developments
  49. 6.9 Protein Sciences Corporation
  50. 6.9.1 Protein Sciences Corporation Company Information
  51. 6.9.2 Protein Sciences Corporation Business Overview
  52. 6.9.3 Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Protein Sciences Corporation DTaP and Tdap Vaccines Product Portfolio
  54. 6.9.5 Protein Sciences Corporation Recent Developments
  55. 6.10 Merck Sharp & Dohme Corp
  56. 6.10.1 Merck Sharp & Dohme Corp Company Information
  57. 6.10.2 Merck Sharp & Dohme Corp Business Overview
  58. 6.10.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product Portfolio
  60. 6.10.5 Merck Sharp & Dohme Corp Recent Developments
  61. 6.11 Emergent BioSolutions Inc
  62. 6.11.1 Emergent BioSolutions Inc Company Information
  63. 6.11.2 Emergent BioSolutions Inc Business Overview
  64. 6.11.3 Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Emergent BioSolutions Inc DTaP and Tdap Vaccines Product Portfolio
  66. 6.11.5 Emergent BioSolutions Inc Recent Developments
  67. 6.12 Astellas Pharma US, Inc
  68. 6.12.1 Astellas Pharma US, Inc Company Information
  69. 6.12.2 Astellas Pharma US, Inc Business Overview
  70. 6.12.3 Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Astellas Pharma US, Inc DTaP and Tdap Vaccines Product Portfolio
  72. 6.12.5 Astellas Pharma US, Inc Recent Developments
7 North America by Country
  1. 7.1 North America DTaP and Tdap Vaccines Sales by Country
  2. 7.1.1 North America DTaP and Tdap Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America DTaP and Tdap Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America DTaP and Tdap Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America DTaP and Tdap Vaccines Market Size by Country
  6. 7.2.1 North America DTaP and Tdap Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America DTaP and Tdap Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America DTaP and Tdap Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe DTaP and Tdap Vaccines Sales by Country
  2. 8.1.1 Europe DTaP and Tdap Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe DTaP and Tdap Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe DTaP and Tdap Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe DTaP and Tdap Vaccines Market Size by Country
  6. 8.2.1 Europe DTaP and Tdap Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe DTaP and Tdap Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe DTaP and Tdap Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific DTaP and Tdap Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific DTaP and Tdap Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific DTaP and Tdap Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific DTaP and Tdap Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific DTaP and Tdap Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific DTaP and Tdap Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific DTaP and Tdap Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific DTaP and Tdap Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America DTaP and Tdap Vaccines Sales by Country
  2. 10.1.1 South America DTaP and Tdap Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America DTaP and Tdap Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America DTaP and Tdap Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America DTaP and Tdap Vaccines Market Size by Country
  6. 10.2.1 South America DTaP and Tdap Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America DTaP and Tdap Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America DTaP and Tdap Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa DTaP and Tdap Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa DTaP and Tdap Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa DTaP and Tdap Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa DTaP and Tdap Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa DTaP and Tdap Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa DTaP and Tdap Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa DTaP and Tdap Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa DTaP and Tdap Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 DTaP and Tdap Vaccines Value Chain Analysis
  2. 12.1.1 DTaP and Tdap Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 DTaP and Tdap Vaccines Production Mode & Process
  7. 12.2 DTaP and Tdap Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 DTaP and Tdap Vaccines Distributors
  10. 12.2.3 DTaP and Tdap Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst